Nuwellis (NUWE) EBIT Growth (3y) (2014 - 2026)
Nuwellis (NUWE) EBIT Growth (3y) (2014 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 180.89 Bn | 173.59 Bn | 6.27 Bn | -3.76% |
| 2 | Stryker | 127.82 Bn | 124.94 Bn | 3.81 Bn | 8.39% |
| 3 | Medtronic | 107.49 Bn | 98.27 Bn | 6.41 Bn | 6.17% |
| 4 | Boston Scientific | 67.24 Bn | 65.78 Bn | 3.61 Bn | 25.88% |
| 5 | Edwards Lifesciences | 48.02 Bn | 44.34 Bn | 1.29 Bn | 7.13% |
| 6 | Dexcom | 28.25 Bn | 27.14 Bn | 750.30 Mn | 75.54% |
| 7 | GE HealthCare Technologies | 28.17 Bn | 25.89 Bn | 1.98 Bn | -2.70% |
| 8 | Smith & Nephew | 26.72 Bn | 26.14 Bn | - | - |
| 9 | Koninklijke Philips | 25.31 Bn | 22.19 Bn | 2.07 Bn | 34.83% |
| 10 | Nuwellis | 112,643.40 | -1.97 Mn | 1.68 Mn | 7.92% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 7.92% |
| Dec 31, 2025 | 18.63% |
| Sep 30, 2025 | 11.72% |
| Jun 30, 2025 | 12.25% |
| Mar 31, 2025 | 11.51% |
| Dec 31, 2024 | 18.01% |
| Sep 30, 2024 | 33.68% |
| Jun 30, 2024 | 21.11% |
| Mar 31, 2024 | 3.09% |
| Dec 31, 2023 | 5.70% |
| Sep 30, 2023 | 9.42% |
| Jun 30, 2023 | -8.61% |
| Mar 31, 2023 | -8.61% |
| Dec 31, 2022 | -0.66% |
| Sep 30, 2022 | 4.54% |
| Jun 30, 2022 | 0.97% |
| Mar 31, 2022 | 2.23% |
| Dec 31, 2021 | -0.61% |
| Sep 30, 2021 | -7.30% |
| Jun 30, 2021 | -4.19% |